Studies Evaluating Visual Outcomes After Brachytherapy in Uveal Melanoma—Strengths and Limitations of Current Investigations

H. Culver Boldt, MD; Timothy G. Murray, MD, MBA; Elaine M. Binkley, MD

Read More

https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2756334

 

Association of Partial Chromosome 3 Deletion in Uveal Melanomas With Metastasis-Free Survival

Manuel Rodrigues, MD, PhD; Khadija Ait Rais, BSc; Flore Salviat, MD; Nathalie Algret; Fatoumata Simaga, MSc; Raymond Barnhill, MD; Sophie Gardrat, MD; Vincent Servois, MD; Pascale Mariani, MD; Sophie Piperno-Neumann, MD; Sergio Roman-Roman, PharmD, PhD; Olivier Delattre, MD, PhD; Nathalie Cassoux, MD, PhD; Alexia Savignoni, MD, PhD; Marc-Henri Stern, MD, PhD; Gaëlle Pierron, PhD

Read More

https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2757831

 

 

COMMENTARY:

Sarah E. Coupland, MBBS, PhD, FRCPath; Sophie Thornton, BSc, PhD; Helen Kalirai, BSc, PhD

Read More

https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2757829

Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma

Carol L. Shields, MD; Lauren A. Dalvin, MD; Michael Chang, MD; Mehdi Mazloumi, MD, MPH; Patricia Fortin, BA; Mark McGarrey, BS; Andrei Martin, MD; Antonio Yaghy, MD; Xiaolu Yang, MD, Ph1; Pornpattana Vichitvejpaisal, MD; Arman Mashayekhi, MD; Jerry A. Shields, MD

Read More

https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2756338

 

 

COMMENTARY:

Culver Boldt, MD; Timothy G. Murray, MD, MBA; Elaine M. Binkley, MD

Read More

https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2756334

 

Visual improvement in amblyopic eye following treatment-induced vision loss in dominant eye with uveal melanoma

Aldo Vagge, Carol L Shields, Jerry A Shields, Renelle Pointdujour-Lim, Bruce Schnall

Read More

https://bjo.bmj.com/content/104/2/202

Categories: BJO

Tags:

Intraocular Metastasis in Unilateral Multifocal Uveal Melanoma Without Melanocytosis or Germline BAP1 Mutations

Michael A. Durante, BS; Scott D. Walter, MD, MSc; Manuel Paez-Escamilla, MD: Julian Tokarev, MD; Christina L. Decatur, BS; Sander R. Dubovy, MD; Amy C. Schefler, MD4; J. William Harbour, MD

Read More

https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2752218

Uveal melanoma incidence trends in Canada: a national comprehensive population-based study

Feras M Ghazawi, Rami Darwich, Michelle Le, Elham Rahme, Andrei Zubarev, Linda Moreau, Julia Valdemarin Burnier, Denis Sasseville, Miguel N Burnier, Ivan V Litvinov

Read More

https://bjo.bmj.com/content/103/12/1872

Categories: BJO

Tags:

Risk-stratified systemic surveillance in uveal melanoma

Jacquelyn M Davanzo, Elaine M Binkley, James F Bena, Arun D Singh

Read More

https://bjo.bmj.com/content/103/12/1868

Categories: BJO

Tags:

Germline variants in the MBD4 gene are rare in patients with uveal melanoma

Pauliina Repo, Johannes Jäntti, Reetta‐Stiina Järvinen, Martin Täll, Virpi Raivio, Tero Kivelä, Joni Turunen

Read More

https://onlinelibrary.wiley.com/doi/10.1111/j.1755-3768.2019.5458

The role of magnetic resonance imaging in diagnosis of uveal melanoma

Rita Serras‐Pereira, Teresa Morais, Luísa Vieira, Carlos Batalha, Joana Ramalho, Ana Duarte, Ana Magriço

Read More

https://onlinelibrary.wiley.com/doi/10.1111/j.1755-3768.2019.5372

Nation‐wide survival outcomes of metastatic uveal melanoma with best supportive care

Elina Rantala , Micaela Hernberg , Tero Kivelä

Read More

https://onlinelibrary.wiley.com/doi/10.1111/j.1755-3768.2019.5219